Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation - Schedule of Unrecognized Compensation Expense (Details)

v3.21.1
Stock-Based Compensation - Schedule of Unrecognized Compensation Expense (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2021
USD ($)
PAVmed Inc 2014 Equity Plan [Member] | Stock Options [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Unrecognized Expense $ 2,419
Weighted Average Remaining Service Period 9 months 18 days
PAVmed Inc 2014 Equity Plan [Member] | Restricted Stock [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Unrecognized Expense $ 1,573
Weighted Average Remaining Service Period 1 year 10 months 25 days
Lucid Diagnostics Inc 2018 Equity Plan [Member] | Stock Options [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Unrecognized Expense $ 36
Weighted Average Remaining Service Period 8 months 12 days
Lucid Diagnostics Inc 2018 Equity Plan [Member] | Restricted Stock [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Unrecognized Expense $ 18,139
Weighted Average Remaining Service Period 1 year 10 months 25 days